Literature DB >> 21290405

Test and power considerations for multiple endpoint analyses using sequentially rejective graphical procedures.

Frank Bretz1, Willi Maurer, Gerhard Hommel.   

Abstract

A variety of powerful test procedures are available for the analysis of clinical trials addressing multiple objectives, such as comparing several treatments with a control, assessing the benefit of a new drug for more than one endpoint, etc. However, some of these procedures have reached a level of complexity that makes it difficult to communicate the underlying test strategies to clinical teams. Graphical approaches have been proposed instead that facilitate the derivation and communication of Bonferroni-based closed test procedures. In this paper we give a coherent description of the methodology and illustrate it with a real clinical trial example. We further discuss suitable power measures for clinical trials with multiple primary and/or secondary objectives and use a generic example to illustrate our considerations.
Copyright © 2011 John Wiley & Sons, Ltd.

Mesh:

Year:  2011        PMID: 21290405     DOI: 10.1002/sim.3988

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Graphical approaches for multiple comparison procedures using weighted Bonferroni, Simes, or parametric tests.

Authors:  Frank Bretz; Martin Posch; Ekkehard Glimm; Florian Klinglmueller; Willi Maurer; Kornelius Rohmeyer
Journal:  Biom J       Date:  2011-08-12       Impact factor: 2.207

2.  Seamless Phase IIa/IIb and enhanced dose-finding adaptive design.

Authors:  Jiacheng Yuan; Herbert Pang; Tiejun Tong; Dong Xi; Wenzhao Guo; Peter Mesenbrink
Journal:  J Biopharm Stat       Date:  2015-09-21       Impact factor: 1.051

3.  Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  José Baselga; Seock-Ah Im; Hiroji Iwata; Javier Cortés; Michele De Laurentiis; Zefei Jiang; Carlos L Arteaga; Walter Jonat; Mark Clemons; Yoshinori Ito; Ahmad Awada; Stephen Chia; Agnieszka Jagiełło-Gruszfeld; Barbara Pistilli; Ling-Ming Tseng; Sara Hurvitz; Norikazu Masuda; Masato Takahashi; Peter Vuylsteke; Soulef Hachemi; Bharani Dharan; Emmanuelle Di Tomaso; Patrick Urban; Cristian Massacesi; Mario Campone
Journal:  Lancet Oncol       Date:  2017-05-30       Impact factor: 41.316

4.  Adaptive graph-based multiple testing procedures.

Authors:  Florian Klinglmueller; Martin Posch; Franz Koenig
Journal:  Pharm Stat       Date:  2014-10-16       Impact factor: 1.894

5.  Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis.

Authors:  Alexander T Hawkins; Jun W Um; Amosy E M'Koma
Journal:  Clin Med Insights Gastroenterol       Date:  2017-12-13

6.  Haplotype Variation of Flowering Time Genes of Sugar Beet and Its Wild Relatives and the Impact on Life Cycle Regimes.

Authors:  Nadine Höft; Nadine Dally; Mario Hasler; Christian Jung
Journal:  Front Plant Sci       Date:  2018-01-04       Impact factor: 5.753

7.  Visual communication in social play of a hierarchical carnivore species: the case of wild spotted hyenas.

Authors:  Andrea Paolo Nolfo; Grazia Casetta; Elisabetta Palagi
Journal:  Curr Zool       Date:  2021-09-16       Impact factor: 2.734

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.